Perspective for Precision Medicine for Tuberculosis
Christoph Lange(Boston University), Andrew R. DiNardo(Baylor College of Medicine), Irina Kontsevaya(Samara Medical Institute Reaviz), Reinout van Crevel(Radboud University Nijmegen), Arjan van Laarhoven(Radboud University Nijmegen), Anna M. Mandalakas(Texas Children's Hospital), Franziska Waldow(Research Center Borstel - Leibniz Lung Center), Jan Heyckendorf(German Center for Infection Research), Morten Rühwald(FIND), Dominik Schwudke(German Center for Infection Research), Matthias Merker(German Center for Infection Research), Stefan Niemann(Research Center Borstel - Leibniz Lung Center), Dumitru Chesov(Research Center Borstel - Leibniz Lung Center), Barbara Kalsdorf(German Center for Infection Research), Hans-Peter Grobbel(German Center for Infection Research), Rob E. Aarnoutse(Radboud University Nijmegen), Maja Reimann(University of Lübeck), Tomoki Nishiguchi(Baylor College of Medicine), Stephen H. Gillespie(University of St Andrews), Niklas Köhler(Research Center Borstel - Leibniz Lung Center), Patricia Sanchez‐Carballo(University of Lübeck)
Cited by 69
Related Papers
Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics
|Journal of Lipid Research|2008|2.6k
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
|New England Journal of Medicine|2014|653
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
Evolution and transmission of drug-resistant tuberculosis in a Russian population
|Nature Genetics|2014|498